Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Completed · Phase 3 · Has a placebo group

Conditions studied: Chronic Myocardial Ischemia, Refractory Angina Pectoris, Advanced Coronary Heart Disease

In brief

The purpose of the study is to assess the safety and efficacy of targeted intramyocardial delivery of Auto-CD34+ cells for increasing exercise time and amelioration of anginal symptoms in subjects with refractory angina and chronic myocardial ischemia.

Key facts

Study ID

NCT01508910

Run by

Lisata Therapeutics, Inc.

People needed

291

Starts

2012-04-01

Expected to finish

2015-11-01

Last updated by the study team

2018-12-19

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Gilbert, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — La Jolla, California, United States
• Study site — Los Angeles, California, United States
• Study site — Oxnard, California, United States
• Study site — San Diego, California, United States
• Study site — Stanford, California, United States
• Study site — Boynton Beach, Florida, United States
• Study site — Daytona Beach, Florida, United States
• Study site — Gainesville, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Augusta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Iowa City, Iowa, United States
• Study site — Louisville, Kentucky, United States
• Study site — New Orleans, Louisiana, United States
• Study site — Boston, Massachusetts, United States
• Study site — Saginaw, Michigan, United States
• Study site — Minneapolis, Minnesota, United States
• Study site — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.